July 22, 2019 / 11:20 PM / a month ago

Merck unit asks U.S. patent office to open new front in CRISPR battle

A Merck AG subsidiary has tried to insert itself into a U.S. Patent and Trademark Office proceeding that will clarify who owns the rights to CRISPR gene editing technology, saying it has a strong inventorship claim but has been treated unfairly by a patent examiner.

In a petition filed on Friday, Sigma-Aldrich Corporation asked the PTO’s director to declare a so-called “interference proceeding” between it and the University of California.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2ObMbRD

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below